STOCK TITAN

Amrize Ltd SEC Filings

AMRZ NYSE

Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.

Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.

Rhea-AI Summary

Amrize Ltd director Roth Pellanda Katja Nicole reported compensation-related share activity. She acquired 2,976 Ordinary Shares at no cost as part of a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. In a separate transaction, 190 Ordinary Shares were disposed of to cover tax obligations at a price of $57.12 per share.

The filing shows 5,744 Ordinary Shares held directly after the award transaction and 2,768 Ordinary Shares held directly after the tax-withholding disposition. The award vests on the earlier of the one-year anniversary of the grant date and the date of Amrize Ltd's next regular annual meeting of shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd director Oleas Jurg Amadeo received a stock award and had shares withheld for taxes. On the reported date, he acquired 2,976 Ordinary Shares at no cost through a grant of restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan. In a related tax-withholding disposition, 157 Ordinary Shares were delivered at a price of $57.12 per share to cover tax obligations on the vesting. After these transactions, he directly owns 20,916 Ordinary Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NEWMAN DONALD P reported acquisition or exercise transactions in this Form 4 filing.

Amrize Ltd director Donald P. Newman received a restricted stock unit award of 2,976 Ordinary Shares. The grant was made at a price of $0.00 per share as equity compensation, increasing his direct holdings to 2,976 shares.

The award was granted under the Amrize Ltd 2025 Omnibus Incentive Plan and will vest on the earlier of the one-year anniversary of the grant date and the date of the company’s next regular annual meeting of shareholders. This is a compensation-related equity grant rather than an open-market share purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amrize Ltd director Michael E. McKelvy reported equity compensation activity involving the company’s ordinary shares. He received 2,976 shares as a grant or award at a stated price of $0.00 per share, tied to a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.

In a related tax-withholding disposition, 740 shares were delivered at $57.12 per share to cover tax obligations upon vesting. Following the tax-withholding transaction, the filing shows McKelvy directly holding 2,218 ordinary shares. The restricted stock units vest on the earlier of one year from grant or the issuer’s next regular annual meeting of shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd director Ladhani Holli C. reported equity compensation activity involving Ordinary Shares. The filing shows a grant of 2,976 shares at no cost as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan, which vests on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

In a related tax-withholding disposition, 740 shares were delivered at a reference price of $57.12 per share, described as the closing price on the vesting date. One line in the filing shows 5,194 shares owned directly following the grant, while another shows 2,218 shares directly owned following the tax-withholding transaction, indicating routine compensation and tax-settlement activity rather than an open-market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd director Sanche Jacques Wolf has filed an initial Form 3 detailing his ownership of the company’s ordinary shares. The filing shows direct ownership of 2,640 ordinary shares and indirect ownership of 40 ordinary shares held by his child, for a total reported interest of 2,680 shares. These entries are reported as holdings rather than new purchases or sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amrize Ltd director Donald P. Newman filed an initial Form 3, which is a required statement of beneficial ownership for new insiders. The filing does not report any stock transactions or derivative positions, serving mainly to put the market on notice that Newman is now an insider of Amrize Ltd.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amrize Ltd reported the results of its 2026 Annual General Meeting, where shareholders approved all major proposals, including financial statements for fiscal 2025 and multiple compensation-related items. Shareholders backed a special cash distribution of USD 0.44 per outstanding share and an ordinary dividend of up to USD 0.44 per outstanding share in up to four installments, returning cash from legal reserves.

Investors strongly supported board members, with each director receiving over 212 million votes in favor, and re-elected Jan Jenisch as chairman. Shareholders also approved maximum aggregate compensation levels for the board and executive management and reappointed Ernst & Young AG as statutory auditor and Ernst & Young LLP for U.S. reporting. Amrize will continue holding annual advisory “say on pay” votes, reflecting the clear preference expressed in the ballot.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
current report
-
Rhea-AI Summary

Amrize Ltd announced that its board has proposed a special one-time dividend of USD $0.44 per outstanding ordinary share, to be paid as a special distribution from legal reserves from capital contributions, subject to shareholder approval at the 2026 Annual General Meeting on April 21, 2026.

If approved, the last trading day with entitlement to the distribution will be April 23, 2026. Shares are expected to trade ex-dividend on or around April 24, 2026, with record dates of April 24, 2026 for New York Stock Exchange shareholders and April 27, 2026 for SIX Swiss Exchange shareholders, and an expected payment date of May 4, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Amrize Ltd executive Oran Baris, the Chief Financial Officer, has filed an initial Form 3, which is the required first ownership report for company insiders. The filing lists him as an officer and, in this excerpt, shows no reported transactions or derivative positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Amrize (AMRZ) SEC filings are available on StockTitan?

StockTitan tracks 85 SEC filings for Amrize (AMRZ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Amrize (AMRZ)?

The most recent SEC filing for Amrize (AMRZ) was filed on April 22, 2026.